Protein kinase C signaling and oxidative stress

Free Radical Biology and Medicine

Volumn 28, Issue 9, 2000, Pages 1349-1361

  Gopalakrishna, Rayudu ^a   Jaken, Susan ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF VERMONT   (United States)

Author keywords

Antioxidants; Cancer prevention; Free radicals; Oxidants; Protein kinase C; Redox regulations; Tumor promotion; Zinc fingers

Indexed keywords

ALPHA TOCOPHEROL; BENZOYL PEROXIDE; CATECHOL; HYDROQUINONE; PERIODATE; PROTEIN KINASE C;

AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; CELL GROWTH; ENZYME ACTIVITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

EID: 0034190297     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00221-5     Document Type: Article

References (138)

1. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. . Science. 258:1992;607-614.
2. Jaken S. Protein kinase C and tumor promoters. . Curr. Opin. Cell Biol. 2:1990;192-197.
3. Bell R.M., Burns D.J. Lipid activation of protein kinase C. J. Biol. Chem. 266:1991;4661-4664.
4. Stabel S., Parker P.J. Protein kinase C. Pharmacol. Ther. 51:1991;71-95.
5. Blumberg P.M. Complexities of the protein kinase C pathway. . Mol .Carcinog. 4:1991;330-344.
6. Gopalakrishna R., Barsky S.H. Tumor promoter-induced membrane-bound protein kinase C regulates hematogenous metastasis. Proc. Natl. Acad. Sci. USA. 85:1988;612-616.
7. 2+ mobilization and protein kinase C activation in the induction of spontaneous metastasis by mouse mammary adenocarcinoma. Cancer Res. 49:1989;2560-2597.
8. Liu B., Honn K.V. Protein kinase C inhibitor calphostin C inhibits B16 melanoma metastasis. Int. J. Cancer Res. 52:1992;147-153.
9. Kiley S.C., Clark K.J., Goodnough M., Welch D.R., Jaken S. Protein kinase Cδ involvement in mammary tumor cell metastasis. Cancer Res. 59:1999;3230-3238.
10. Kiley, S. C.; Clark, K. J.; Duddy, S. K.; Welch, D. R.; Jaken, S. Increased protein kinase Cδ in mammary tumor cells: Relationship to transformation and metastatic progression. Oncogene 18:6748-6757; 1999.
11. Cohen P., Holmes C.F.B., Tsukitani Y. Okadaic acid a new probe for the study of cell regulation . Trans. Biochem. Sci. 15:1990;98-102.
12. 2+-, and phospholipid-independent activation of protein kinase C by selective oxidative modification of regulatory domain. Proc. Natl. Acad. Sci. USA. 86:1989;6758-6762.
13. Gopalakrishna R., Anderson W.B. Reversible oxidative activation and inactivation of PKC by the mitogen/tumor promoter periodate. Arch. Biochem. Biophys. 285:1991;38-387.
14. Gopalakrishna R., Chen Z.H., Gundimeda U. Tobacco smoke tumor promoters, catechol and hydroquinone induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. . Proc. Natl. Acad. Sci. USA. 91:1994;12233-12237.
15. Kass G.E.N., Duddy S.K., Orrenius S. Activation of hepatocyte protein kinase C by redox-cycling quinones. Biochem. J. 260:1989;499-507.
16. Larsson R., Cerutti P. Translocation and enhancement of phosphotransferase activity of protein kinase C following exposure of mouse epidermal cells to oxidants. Cancer Res. 49:1989;5627-5633.
17. Gopalakrishna R., Chen Z.H., Gundimeda U. Modification of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and the enzyme specific inhibitors. Meth. Enzymol. 252:1995;134-148.
18. Boscoboinik D., Szewczyk A., Hensey C., Azzi A. Inhibition of cell proliferation by α-tocopherol. Role of protein kinase C. J. Biol. Chem. 266:1991;6188-6194.
19. Gopalakrishna R., Gundimeda U., Chen Z. Cancer preventive selenocompounds induce a specific redox modification of cysteine-rich regions in calcium-dependent isoenzymes of protein kinase C. Arch. Biochem. Biophys. 348:1997;25-36.
20. Chen Z., Gundimeda U., Gopalakrishna R. Curcumin irreversibly inactivates protein kinase C activity and phorbol ester binding its possible role in cancer chemoprevention (abstract) . Proc. Am. Assoc. Cancer Res. 37:1996;A1922.
21. Suziki Y.J., Forman H.J., Sevanian A. Oxidants as stimulators of signal transduction. Free Radic. Biol. Med. 22:1997;269-285.
22. Meyer M., Schreck R., Muller J.M., Baeuerle P.A. Redox control of gene expression by eukaryotic transcription factors NF-κB, AP-1 and SRF/TCF. Pasquier C., Auclair C., Olivier R.Y., Packer L., Oxidative stress, cell activation and viral infection. 1994;217-235 Birkhauser Verlag, Switzerland.
23. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18:1995;775-794.
24. 2 for platelet-derived growth factor signal transduction. Science. 270:1995;296-299.
25. Bae Y.S., Kang S.W., Seo M.S., Baines I.C., Tekle E., Chock P.B., Rhee S.G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. . J. Biol. Chem. 272:1997;217-221.
26. 2 is an important mediator of UVB-induced EGF-receptor phosphorylation in cultured kertatinocytes. J. Invest. Dermatol. 110:1998;966-971.
27. Travers J.B. Oxidative stress can activate the epidermal platelet-activating factor receptor. J. Invest. Dermatol. 112:1999;279-283.
28. Sevanian A., Kim E. Phospholipase A2-dependent release of fatty acids from peroxidized membranes. Free Radic. Biol. Med. 1:1985;227-263.
29. Natarajan V., Taher M.M., Roehm B., Parinandi N.L., Schmid H., Kiss Z., Garcia J.G. Activation of endothelial cell phospholipase D by hydrogen peroxide and fatty acid peroxide. J. Biol. Chem. 268:1993;930-937.
30. 2 in Swiss 3T3 fibroblasts. J. Biol. Chem. 273:1998;29986-29994.
31. Schieven G.L., Kirihara J.M., Burg D.L., Geahlen R.L., Ledbetter J.A. Syk tyrosine kinase is activated by oxidizing conditions which induce lymphocyte tyrosine phosphorylation and calcium signals. J. Biol. Chem. 268:1993;16688-16692.
32. Nakamura K., Hori T., Sato N., Sugie K., Kawakami T., Yodi J. Redox regulation of src family protein tyrosine kinase p56lck in T cells. Oncogene. 8:1993;3133-3139.
33. Liu Y., Gorospe M., Yang C., Holbrook N.J. Role of mitogen-activated protein kinase phospahtase during the cellular response genotoxic stress. J. Biol. Chem. 270:1995;8377-8380.
34. Milligan S.A., Owens M.W., Grisham M.B. Differential regulation of extracellular signal-regulated kinase and nuclear factor-kappa B signal transduction pathways by hydrogen peroxide and tumor necrosis factor. Arch. Biochem. Biophys. 352:1998;255-262.
35. Fialkow L.C., Chan K., Rotin D., Grinsten S., Downey G.P. Activation of the mitogen-activated protein kinase signaling pathway in neutrophils role of oxidants . J. Biol. Chem. 269:1994;31234-31242.
36. Adler V., Schaffer A., Kim J., Dolan L., Ronai Z. UV irradiation and heat shock mediate JNK activation via alternate pathways. J. Biol. Chem. 270:1995;26071-26077.
37. Schicke S.M., Briviba K., Klotz L.O., Sies H. Activation of mitogen-activated protein kinases elicited by peroxynitrite attenuation by selenite supplementation . FEBS Lett. 448:1999;301-303.
38. Karin M. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann. N. Y. Acad. Sci. 851:1998;139-146.
39. Abate C., Patel L., Rauscher F.J. III, Curran T. Redox regulation of Fos and Jun DNA -binding activity in vitro. Science. 249:1990;1157-1161.
40. Anderson M.T., Staal F.J.T., Gitler C., Herzenberg L.A., Herzenberg L.A. Separation of oxidant-initiated and redox-regulated steps in the NF-κB signal transduction pathway. Proc. Natl. Acad. Sci. USA. 91:1994;11527-11531.
41. Toledano M.B., Leonard W.J. Modulation of transcription factor NF-κB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;4328-4332.
42. Matthews J.R., Wakasugi N., Virelizier J.L., Yodoi J., Hay R.T. Thioredoxin regulates the DNA binding activity of NF-κB by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:1992;3821-3830.
43. Flohe L., Brigelius-Flohe R., Salioui L., Traber M.G., Packer L. Redox regulation of NF-κB activation. Free Radic. Biol. Med. 22:1997;1115-1126.
44. Sun Y., Oberley L.W. Redox regulation of transcriptional activators. Free Radic. Biol. Med. 21:1996;35-348.
45. Zhang Z., Ynag X.Y., Cohen D.M. Urea-associated oxidative stress and Gadd153/CHOP induction. Am. J. Physiol. 276:1999;F786-F793.
46. Carballo M., Conde M., El Bekay R., Martin-Nieto J., Camacho M.J., Monteseirin J., Conde J., Bedoya F.J., Sobrino F. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation of in human lymphocytes. J. Biol. Chem. 274:1999;17580-17586.
47. Gilbert H.F. Molecular and cellular aspects of thiol-disulfide exchange. Adv. Enzymol. Rel. Areas Mol. Biol. 63:1990;69-172.
48. Ziegler D.M. Role of reversible oxidation-reduction of enzyme thiols disulfides in metabolic regulation. Ann. Rev. Biochem. 54:1985;305-329.
49. Garcia-Morales P., Minami Y., Luong E., Klausner R.D., Samelson I.E. Tyrosine phosphorylation in T cells is regulated by phosphatase activity studies with phenylarsine oxide . Proc. Natl. Acad. Sci. USA. 87:1990;9255-9259.
50. 2 and vanadate administration into rat livers. Mol. Cell. Endocrinol. 97:1993;9-17.
51. Sullivan S.G., Chiu D.T.Y., Errrasfa M., Wang J.M., Qui J.S., Stern A. Effects of hydrogen peroxide on protein tyrosine phospahtase activity in HER 14 cells. Free Radic. Biol. Med. 16:1994;399-403.
52. Lander H.M., Ogiste J.S., Teng K.K., Novogrodsky A. p21 ras as a common signaling target of reactive free radicals and cellular redox stress. J. Biol. Chem. 270:1995;21195-21198.
53. Deora A.A., Win T., Vanhaesebroeck B., Lander H.M. A redox-triggered ras-effector interaction recruitment of phosphatidyl 3′-kinase to ras by redox stress . J. Biol. Chem. 273:1998;29923-29928.
54. Ueda Y., Hirai S.-I., Osada S.-I., Suziki A., Mizuno K., Ohno S. Protein kinase C delta activates the MEK-ERK pathway in a manner independent of ras and dependent on Raf. J. Biol. Chem. 38:1996;23519-23612.
55. Li J.J., Westergaard C., Ghosh P., Colburn N.H. Inhibitors of both nuclear factor-κB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 57:1997;3569-3576.
56. Conricode K.M., Brewer K.A., Exton J.H. Activation of phospholipase D by protein kinase C. Evidence for a phosphorylation independent mechanism. J. Biol. Chem. 267:1992;7199-7202.
57. Zor U., Ferber E., Gergely K., Scucs K., Dobradi V., Goldman R. Reactive oxygen species medaite phorbol ester-regulated tyrosine phosphorylation and phospholipase A2 activation. Potentiation by vanadate. Biochem. J. 295:1993;879-888.
58. Slaga T.J., Kleen-Szanto A.J.P., Triplet L.L., Yotti L.P., Trosko J.E. Skin Tumor promoting activity of benzoyl peroxide, a widely used free radical generating compound. Science. 213:1981;1023-1025.
59. Trush M.A., Kensler T.W. An overview of the relationship between oxidative stress and chemical carcinogenesis. Free Radic. Biol. Med. 10:1991;201-209.
60. Cerutti P.A. Prooxidant states and tumor promotion. Science. 227:1985;375-381.
61. Frenkel K., Chrzan K. Hydrogen peroxide formation and DNA modification by tumor promoter-activated polymorphonuclear leukocytes. Carcinogenesis. 8:1987;455-460.
62. Fischer S.M., Furstenberger G., Marks F., Slaga T.J. Events associated with mouse skin tumor promoters with respect to arachidonic acid metabolism a comparison between SENCAR and NMRI mice . Cancer Res. 47:1987;3174-3179.
63. Weitzman S.A., Weitberg A.B., Clark E.P., Stossel T.P. Phagocytes as carcinogens malignant transformation produced by human neutrophils. Science. 227:1985;1231-1233.
64. Nguyen T.T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation in human cells exposed to nitric oxide. Proc. Natl. Acad. Sci. USA. 89:1992;3030-3034.
65. Schmidt K.N., Traneckner E.B.M., Meier B., Baeuerle P.A. Induction of oxidative stress by okadaic acid is required for activation of transcription factor NF-κB. J. Biol. Chem. 270:1995;27136-27142.
66. Srinivas L., Colburn N.H. Preferential oxidation of cell surface salic acid by periodate leads to promotion of transformation in JB6 cells. Carcinogenesis. 5:1984;515-519.
67. Aiyar J., Berkovits H.J., Floyd R., Wetterhahn K.E. Reaction of chromium (VI) with glutathione or with hydrogen peroxide identification of reactive intermediates and their role in chromium (VI)-induced DNA damage . Environ. Health Perspect. 92:1991;53-62.
68. Marsh J.P., Mossman B.T. Role of asbestos and active oxygen species in activation of and expression of ornithine decarboxylase in hamster tracheal epithelial cells. Cancer Res. 51:1991;167-173.
69. Hei T.K., Wu L.J., Piao C.O. Malignant transformation of immortalized human bronchial epithelial cells by asbestos fibers. Environ. Health Perspect. 105:1997;1085-1088.
70. Hoffmann D., Hecht S.S., Wynder E.L. Tumor promoters and cocarcinogens in tobacco carcinogenesis. Environ. Health Prospec. 50:1983;247-257.
71. Pryor W.A., Stone K. Oxidants in cigarette smoke radicals, hydrogen peroxide, peroxynitrate and peroxynitrite. Ann. N. Y. Acad. Sci. 686:1992;12-27.
72. Wattenberg L.W. Inhibition of neoplasia by minor dietary constitutents. Cancer Res. 43:(Suppl.):1983;2448s-2455s.
73. Boone C.W., Kelloff G.J., Malone W.E. Identification of candidate cancer chemopreventive agents and their evaluation in animal and human clinical trails. Cancer Res. 50:1990;2-9.
74. Bertram J.S., Kolonel L.N., Meyskens F.L. Jr. Rationale and strategies for chemoprevention of cancer in humans. Cancer Res. 47:1987;3012-3031.
75. Quest A.F.G., Bloomenthal J., Bardes E.S.G., Bell R.M. The regulation domain of protein kinase C coordinartes four atoms of zinc. J. Biol. Chem. 267:1992;10193-10197.
76. Kazanietz M.G., Wang S., Milne G.W.A., Lewin N.E., Liu H.L., Blumberg P.M. Residues in the second cysteine-rich region of protein kinase C relevant to phorbol ester binding as revealed by site-directed mutagenesis. J. Biol. Chem. 270:1995;21852-21859.
77. Zhang G., Kazanietz M.G., Blumberg P.M., Hurley J.G. Crystal Structure of the Cys2 activator-binding domain of protein kinase C delta in complex with phorbol ester. Cell. 81:1995;917-924.
78. Sunderman F.W., Barber A.M. Finger-loops, oncogenes, and metals. Ann. Clin. Lab. Sci. 18:1988;267-288.
79. Lin Y.L., Shiveji M.K.K., Chen C., Kolodner R., Wood R.D., Dutta A. The evolutionarily concesrved zinc finger motif in the largest subunit of human replication protein is required for DNA replication of mismatch repair but not for nucleotide excision repair. J. Biol. Chem. 273:1998;1453-1460.
80. Maret W., Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. USA. 95:1998;3478-3482.
81. Jiang L.J., Maret W., Vallee B.L. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbital dehydrogenase. Proc. Natl. Acad. Sci. USA. 95:1998;3483-3488.
82. Crow J.P., Beckman J.S., McCord J.M. Sensitivity of the essential zinc-thiolate moiety of yeast alcohol dehydrogenase to hypochlorite and peroxynitrite. Biochem. J. 34:1995;3544-3552.
83. Bray T.M., Bettger W.J. The physiological role of zinc as an antioxidant. Free Radic. Biol. Med. 8:1990;281-291.
84. Fong L.Y.Y., Farber J.L., Magee P.N. Zinc replensihment reduces esophageal cell proliferation and n-nitrosomethylbenzylamine-induced esophageal tumor incidence in zinc deficient rats. Carcinogenesis. 19:1998;1591-1596.
85. Kikkawa U., Ogita K., Ono Y., Asaoka Y., Shearman M.S., Fujii T., Ase K., Sekiguchi K., Igarashi K., Nishizuka Y. The common structure and activities of four species of rat brain protein kinase C family. FEBS Lett. 223:1987;212-216.
86. Gopalakrishna R., Chen Z., Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of PKC and phorbol ester binding. J. Biol. Chem. 268:1993;27180-27185.
87. Ward N.E., Graven K.R., O'Brian C.A. Covalent modification of protein kinase C by the inactivating peptide substrate analog N-biotinyl-Arg-Arg-Arg-Cys-Leu-Arg-Arg-Leu. J. Biol. Chem. 271:1997;24193-24200.
88. Gundimeda U., Chen Z., Gopalakrishna R. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J. Biol. Chem. 271:1995;13504-13514.
89. Gopalakrishna R., Chen Z., Gundimeda U., Kensler T. Reversible inactivation of protein kinase C by oltipraz through reaction with the catalytic domain role in inhibition of tumor promotion (abstract) . Proc. Am. Assoc. Cancer Res. 37:1996;A1817.
90. Tylor C., Nagy L., Bray T.M. Nutritional regulation of glutathione homeostasis. Curr. Topics Cell. Regul. 34:1996;189-208.
91. Park S.H., Aust A.E. Regulation of nitric oxide synthase induction by iron and glutathione in asbestos-treated human lung epithelial cells. Arch. Biochem. Biophys. 360:1998;47-52.
92. Coan C., Ji J., Hideg K., Mehlhorn R.J. Protein sulfhydryls are protected from irreversible oxidation by conversion to mixed disulfides. Arch. Biochem. Biophys. 295:1992;369-378.
93. Gopalakrishna R., Chen Z.H., Gundimeda U. Selenocompounds induce a redox modulation of protein kinase C in the cell, compartmentally independent from cytosolic glutathione its role in inhibition of tumor promotion . Arch. Biochem. Biophys. 348:1997;37-48.
94. Gopalakrishna R., Gundimeda U., Anderson W.B., Colburn N.H., Slaga T.J. Tumor promoter benzoyl peroxide induces sulfhydryl oxidation in protein kinase C its reversibility is related to the cellular resistance to peroxide-induced cytotoxicity . Arch. Biochem. Biophys. 363:1999;246-258.
95. Jaken, S.; Parker, P. J. Protein kinase C binding proteins. Bioassays 22:245-254; 2000.
96. Liao L., Ramsay K., Jaken S. Protein kinase C isoenzymes in progressively transformed rat embryo fibroblasts. Cell Growth Differ. 5:1994;1185-1194.
97. Kiley S.C., Jaken S., Whelan R., Parker P.J. Intracellular targeting of protein kinase C isoenzymes functional implications . Biochem. Soc. Trans. 23:1995;601-605.
98. Ward N.E., Pierce D.S., Chung S.E., Gravitt K.R., O'Brian C.A. Irreversible inactivation of protein kinase C by glutathione. J. Biol. Chem. 273:1998;12558-12566.
99. Taher M.M., Garcia J.G., Natarajan V. Hydroperoixde-induced diacylglycerol formation and protein kinase C activation in vascular endothelial cells. Arch. Biochem. Biophys. 303:1993;260-266.
100. Whisler R.L., Goyette M.A., Grants I.S., Newhouse Y.G. Sublethal levels of oxidant stress stimulate multiple serine/threonine kinases and suppress protein phosphatases in jurkat T cells. Arch. Biochem. Biophys. 319:1995;23-35.
101. Palumbo E.J., Sweatt J.D., Chen S.J., Klann E. Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates. Biochem. Biophys. Res. Commun. 187:1992;1439-1445.
102. Brawn M.K., Chiou W.J., Leach K.L. Oxidant-induced activation of protein kinase C in UC11MG cells. Free Radic. Res. 22:1995;23-37.
103. Kaul N., Gopalakrishna R., Gundimeda U., Choi J., Forman H.J. Role of protein kinase C in basal and hydrogen peroxide peroxide-stimulated NF-κB activation in the murine macrophage J774A.1 cell line. Arch. Biochem. Biophys. 350:1998;79-86.
104. 2. Proc. Natl. Acad. Sci. USA. 94:1997;11233-11237.
105. Rao G.N., Lassegue B., Griendling K.K., Alexander W.R. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells role of arachidonic acid . Oncogene. 8:1993;2759-2764.
106. Stauble B., Boscoboinik D., Tasinato A., Azzi A. Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-α-tocopherol in vascular smooth muscle cells. Eur. J. Biochem. 226:1994;393-402.
107. Amstad P.A., Krupitza G., Cerutti P.A. Mechanism of c-fos induction by active oxygen. Cancer Res. 52:1992;3952-3960.
108. Cerutti P., Krupitza G., Larsson R., Muehlematter D., Crawford D., Amstad P. Physiological and pathological effects of oxidants in mouse epidermal cells. Ann. N. Y. Acad. Sci. 551:1988;75-82.
109. Gindhart T.D., Srinivas L., Colburn N.H. Benzoyl peroxide promotion of transformation of JB6 mouse peidermal cells. Carcinogenesis. 6:1985;309-311.
110. Klein-Szanto A.J.P., Slaga T.J. Effects of peroxides on rodent skin epidermal hyperplasia and tumor promotion . J. Invest. Dermatol. 79:1982;30-34.
111. 3H]phorbol 12,13-dibutyrate binding by various tumor promoters in mouse brain cytosol. Cancer Res. 45:1985;1958-1963.
112. Donnelly T.E. Jr, Pelling J.C., Anderson C.L., Dalby D. Benzoyl peroxide activation of protein kinase C activity in epidermal cell membranes. Carcinogenesis. 8:1987;1871-1874.
113. Kumar R., Holian O. Inhibition of mouse skin protein1 kinase C by benzoyl peroxide. J. Invest. Dermatol. 96:1991;490-494.
114. Hagemann I., Toso S.M., Kitay K., Webster G.F. Anti-inflammatory actions of benzoyl peroxide effects on the generation of reactive oxygen species by leucocytes and the activity of protein kinase C and calmodulin . Br. J. Dermatol. 130:1994;569-575.
115. Matsui M.S., Mintz E., Deleo V.A. Effect of benzoyl peroxide on protein kinase C in cultured human epidermal keratinocytes. Skin Pharmacol. 8:1995;130-138.
116. Pryor W.A., Bickley H.T. The accelrated decomposition of benzoyl peroxide in the presence of sulfites and disulfides. J. Org. Chem. 37:1972;2885-2893.
117. Akman S.A., Kensler T.W., Doroshow J.H., Diadaroglu M. Copper ion-mediated modification of bases in DNA in vitro by benzoyl peroxide. Carcinogenesis. 14:1993;1971-1974.
118. Sweetman L.L., Zhang N.Y., Peterson H., Gopalakrishna R., Sevanian A. Effect of linoleic acid hydroperoxide on endothelial cell calcium homeostasis and phospholipid hydrolysis. Arch. Biochem. Biophys. 323:1995;97-107.
119. O'Brian C.A., Ward N.E., Weinstein I.B., Bull A.W., Marnett L.J. Activation of rat brain protein kinase C by lipid oxidation products. Biochem. Biophys. Res. Commun. 155:1988;1374-1380.
120. Willey J.C., Grafstrom R.C., Moser C.E., Ozanne C., Sundqvist K., Harris C.C. Biochemical and morphological effects of cigarette smoke condensate and its fractions on normal human bronchial epithelial cells in vitro. Cancer Res. 47:1987;2045-2049.
121. Johnston-Early A., Cohen M.H., Minna J.D., Paxton L.M., Fossieck B.E., Ihde D.C., Bunn P.A., Matthews M.J., Makuch R. Smoking abstinence and small cell lung cancer survival. JAMA. 244:1980;2175-2179.
122. Daniell H.W. Increased lymph node metastases at mastectomy for breast cancer associated with host obesity, cigarette smoking, age, and large tumor size. Cancer. 62:1988;429-435.
123. Ip C., Ganther H.E. Activity of methylated forms of selenium in cancer prevention. Cancer Res. 50:1990;1206-1211.
124. Medina D., Shepherd F. Selenium-mediated inhibition of 7,12-dimethylbenzo( a )anthracene-induced mouse mammary tumorigenesis. Carcinogenesis. 2:1981;451-455.
125. Clark L.C., Combs G.F., Tumbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher J.L. Jr, Park H.K., Sanders B.B. Jr, Smith C.L., Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA. 276:1996;1957-1963.
126. Sundae R.A. The Biochemistry of selenoproteins. J. Am. Chem. Soc. 61:1984;1893-1900.
127. Burk R.F., Hill K.E. Regulation of selenoproteins. Ann. Rev. Nutr. 13:1993;65-81.
128. Sinha R., Kiley S.C., Lu J.X., Moraes R., Thompson H.J., Jaken S., Medina D. Methylselenocysteine inhibits mouse mammary growth by altering PKC enzyme activity (abstract). Proc. Am. Assoc. Cancer Res. 38:(Suppl.):1998;A1816.
129. Ganther H.E., Corcoran C. Selenotrisulfides II. Cross-linking of reduced pancreatic ribnuclease with selenium. Biochemistry. 8:1969;2557-2563.
130. Gladyshev V.N., Jeang K.T., Stadtman T.C. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA. 93:1996;6146-6151.
131. Spyrou G., Bjornstedt M., Kumar S., Holgren A. AP-1 DNA-binding activity is inhibited by selenite and selenodiglutathione. FEBS Lett. 368:1995;59-63.
132. Kim I.Y., Stadtman T.C. Inhibition of NF-κB DNA binding and nitric oxide induction in human T cells and lung carcinoma cells by selenite treatment. Proc. Natl. Acad. Sci. USA. 94:1997;12904-12907.
133. Lu Y.P., Chang R.L., Lou Y.R., Huang M.T., Newmark H.L., Reuhl K.R., Conney A.H. Effect of Curcumin on 12-O-tetradecanoylphorbol-13-acetate and ultraviolet B light-induced expression of c-jun and c-fos in JB6 cells and in mouse epidermis. Carcinogenesis. 15:1994;2363-2368.
134. Lin J.K., Shih C.A. Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis. 15:1994;1717-1721.
135. Lui J.Y., Lin S.J., Lin J.K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-0-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis. 14:1993;857-861.
136. Prasad K.N., Edwards-Prasad J. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cell s in culture. Cancer Res. 42:1982;550-555.
137. Kline K., Cochran G.S., Sanders B.G. Growth-inhibitory effects of vitamin E succinate on retrovirus-transformed tumor cells in vitro. Nutr. Cancer. 14:1990;27-41.
138. Gopalakrishna R., Gundimeda U., Chen Z. Vitamin E succinate inhibits protein kinase C correlation with its unique inhibitory effects on cell growth and transformation . Prasad K.N., Nutrients and cancer. 1995;21-37 Humana Press, Totawa, NJ.